SnapshotDx Quiz: May 2022

    Jordan Phillipps, Neel S. Raval, Amy Musiek
    TLDR Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.
    The "SnapshotDx Quiz: May 2022" from the Journal of Investigative Dermatology focuses on diagnosing androgenetic alopecia (AGA), a common form of hair loss affecting up to 50% of males and females. AGA is characterized by a heightened response to androgens, leading to progressive hair thinning and follicular miniaturization. The quiz highlights that AGA typically presents with bitemporal thinning in men and vertex thinning in women. The pathogenesis involves increased androgen receptor activity, and first-line treatments include topical minoxidil and finasteride. The document also discusses differential diagnoses such as telogen effluvium, central centrifugal cicatricial alopecia, trichotillomania, and alopecia areata sisaipho, providing detailed descriptions and distinguishing features for each condition.
    Discuss this study in the Community →

    Research cited in this study

    18 / 18 results

    Related Community Posts Join

    6 / 1000+ results
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 3 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community Quit vaping/smoking = 80% less loss

      in Research/Science  235 upvotes 7 months ago
      Quitting vaping significantly reduced hair loss for a user who was a heavy vaper and also taking finasteride. Some participants suggest nicotine's vasoconstrictive properties may worsen hair loss, while others share personal anecdotes of hair improvement after quitting smoking or vaping.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  39 upvotes 1 year ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

      community It’s over. NOTHING has worked.

      in Chat  95 upvotes 1 year ago
      A user who has been trying various treatments for hair loss for four years, with no success. Suggestions include use of minoxidil, finasteride, RU58841, microneedling, supplements and multivitamins, lifestyle changes, scalp biopsy, and SMP.

    Similar Research

    5 / 1000+ results